miR-20b, -21 and -130b upregulated PD-L1 expression in colorectal cancer also by targeting PTEN [112], while miR-135 augmented PD-L1 expression in lung cancer by suppressing the ubiquitination of proteins in the JAK/STAT signaling pathway [113]. Here, CD274 is linked to lung carcinoma.